Literature DB >> 11860174

Peripheral decrease and pulmonary homing of CD4+CD45RO+ helper memory T cells in cystic fibrosis.

M Häusler1, K Schweizer, S Biesterfel, T Opladen, G Heimann.   

Abstract

Interstitial lung disease, although of prognostic impact for patients with cystic fibrosis (CF), remains difficult to assess without histopathologic investigations. As changes of peripheral blood lymphocyte subsets (LS) may accompany severe systemic lymphocyte immune responses, we compared peripheral LS of 44 patients with CF, 23 non-CF patients with recurrent pulmonary infections and 83 healthy controls (flow cytometry; CD3, CD19, CD16, CD56, CD4, CD8, CD11b, CD45RA, CD45RO, HLA-DR and CD25 antigens). Additional immunohistochemistry was performed on lung tissue of four CF patients aged 0.5, 12, 17 and 20 years, respectively. Patients with CF showed low absolute counts of CD4+CD45RO+ memory helperT cells, CD16+CD56+ NK cells, CD8+ and interleukin-2 receptor-positive T cells in peripheral blood (P < 0.001). Similar changes were registered in the non-CF patients with pulmonary infections, indicating that those were not specific for CF. Immunohistochemistry showed activation of bronchus-associated lymphoid tissue with interstitial accumulation of CD4+CD45 RO+ T cells in the three older patients. Patients with CF show marked changes of peripheral blood LS which are presumably not CF-specific and may mirror homing to lung tissue in the course of interstitial lung disease. Further research should evaluate its usefulness in monitoring progression of lung disease in CF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860174     DOI: 10.1053/rmed.2001.1217

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia.

Authors:  Dennis Rosen; Jong-Hwan Lee; Frank Cuttitta; Fatema Rafiqi; Simone Degan; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2006-03-30       Impact factor: 21.405

3.  Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients.

Authors:  C Hubeau; R Le Naour; M Abély; J Hinnrasky; M Guenounou; D Gaillard; E Puchelle
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

4.  High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.

Authors:  Emily M Mulcahy; Jo B Hudson; Sean A Beggs; David W Reid; Louise F Roddam; Margaret A Cooley
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

5.  Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  Daniel J Smith; Geoffrey R Hill; Scott C Bell; David W Reid
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

6.  End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: an immunohistochemical analysis.

Authors:  Elise J Lammertyn; Elly Vandermeulen; Hannelore Bellon; Stephanie Everaerts; Stijn E Verleden; Kathleen Van Den Eynde; Ken R Bracke; Guy G Brusselle; Pieter C Goeminne; Erik K Verbeken; Bart M Vanaudenaerde; Lieven J Dupont
Journal:  Respir Res       Date:  2017-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.